What is neoadjuvant therapy for liver cancer?
Neoadjuvant therapy is defined as preoperative adjuvant therapy for unresectable liver cancer, which allows the tumor to shrink and stage lower, giving the patient the opportunity for surgical resection and thus improving survival.
What are the approaches?
Neoadjuvant therapy for hepatocellular carcinoma includes hepatic artery ligation cannulation, arterial embolization chemotherapy/arterial embolization, and radiation therapy. After treatment, patients need a series of tests, including imaging, to re-evaluate whether surgery can be performed.